-
1Academic Journal
Subject Terms: SARS-Cov-2, COVID-19, пути передачи, особенности распространения, индивидуальная восприимчивость
Relation: https://zenodo.org/communities/covid-19/; https://zenodo.org/records/4366684; oai:zenodo.org:4366684; https://doi.org/10.33384/26587270.2020.04.02.01r
-
2Academic Journal
Authors: O S. Vasil'eva, L. P. Kuz'mina, N. Yu. Kravchenko, О. С. Васильева, Л. П. Кузьмина, Н. Ю. Кравченко
Source: PULMONOLOGIYA; Том 27, № 2 (2017); 198-205 ; Пульмонология; Том 27, № 2 (2017); 198-205 ; 2541-9617 ; 0869-0189 ; 10.18093/0869-0189-2017-27-2
Subject Terms: персонифицированная профилактика, chronic obstructive pulmonary disease, work-related factors, individual susceptibility, molecular biomarkers, personalized approach, prevention, хроническая обструктивная болезнь легких, профессиональные факторы, индивидуальная восприимчивость, генетические маркеры
File Description: application/pdf
Relation: https://journal.pulmonology.ru/pulm/article/view/843/709; Bang K.M. Chronic obstructive pulmonary diseases in nonsmokers by occupation and exposure: a brief review. Curr. Opin. Pulm. Med. 2015, 21 (2): 149–154. DOI:10.1097/MCP.0000000000000135.; Baur X., Sigsgaard T., Aasen T.B. et al. Guidelines for the management of work-related asthma. Eur. Respir. J. 2012; 39 (3): 529–545. DOI:10.1183/09031936.00096111.; Nicholson P.J., Cullinan P., Burge P.S., Boyle C. Occupational asthma: Prevention, identification and management: Systematic review and recommendations. London: British Occupational Health Research Foundation; 2010. Available at: http://www.bohrf.org.uk/downloads/OccupationalAsthmaEvidenceReview-Mar2010.pdf; Henneberger P.K., Redlich C.A., Callahan D.B. et al. An official American Thoracic Society statement: work-exacerbated asthma. Am. J. Respir. Crit. Care Med. 2011; 184 (3): 368–378. DOI:10.1164/rccm.812011ST.; Tarlo S., Cullinan P., Nemery B., eds. Occcupational and Environmental Lung Diseases: Diseases from Work, Home, Outdoor and Other Exposures. Oxford: Wiley-Blackwell; 2010.; Lopez A.D., Shibuya K., Rao C. et al. Chronic obstructive pulmonary disease: current burden and future projections. Eur. Respir. J. 2006; 27 (2): 397–412. DOI:10.1183/09031936.06.00025805.; Salvi S. Tobacco smoking and environmental risk factors for chronic obstructive pulmonary disease. Clin. Chest Med. 2014; 35 (1): 17–27. DOI:10.1016/j.ccm.2013.09.011.; American Lung Association. Chronic Obstructive Pulmonary Disease (COPD) Fact Sheet. 2014. Available at: http://www.lung.org/lung-disease/copd/resources/facts-figures/COPD-Fact-Sheet.html; Fishwick D., Sen D., Barber C. et al. Occupational chronic obstructive pulmonary disease: a standard of care. Occup. Med. (Lond.). 2015; 65 (4): 270–282. DOI:10.1093/occmed/kqv019.; Bang K.M., Syamlal G., Mazurek J.M., Wassell J.T. Chronic obstructive pulmonary disease prevalence among nonsmokers by occupation in the United States. J. Occup. Environ. Med. 2013; 55 (9): 1021–1026. DOI:10.1097/JOM.0b013e31829baa97.; Hnizdo E., Sullivan P.A., Bang K.M., Wagner G. Association between chronic obstructive pulmonary disease and employment by industry and occupation in the US population: a study of data from the Third National Health and Nutrition Examination Survey. Am. J. Epidemiol. 2002; 156 (8): 738–746.; Evans J., Chen Y., Camp P.G. et al. Estimating the prevalence of COPD in Canada: Reported diagnosis versus measured airflow obstruction. Health Rep. 2014; 25 (3): 3–11.; Lamprecht B., McBurnie M.A., Vollmer W.M. et al. COPD in never smokers: results from the population-based burden of obstructive lung disease study. Chest. 2011; 139 (4): 752–763. DOI:10.1378/chest.10-1253.; Christiani D.S., Mehta A.J., Yu C.L. Genetic susceptibility to occupational exposures. Occup. Environ. Med. 2008; 65 (6): 430–436. DOI:10.1136/oem.2007.033977.; Shulte P.A., Whittaker C., Curran C.P. Consideration for Using Genetics and Epigenetic Information in Occupational Health Risk Assessment and Standard Settings. J. Occup. Inviron. Hyg. 2015; 12 (Suppl. 1): S69–S68. DOI:10.1080/15459624.2015.1060323.; Brandt-Rauf P.W., Brandt-Rauf S.I. Genetic testing in the workplace: ethical, legal, and social implications. Ann. Rev. Public Health. 2004; 25: 139–153. DOI:10.1146/annurev.publhealth.25.101802.123012.; Chiu W.A., Euling S.Y., Scott C.S., Subramaniam R.P. Approaches to advancing quantitative human health risk assessment of environmental chemicals in the post-genomic era. Toxicol. Appl. Pharmacol. 2013; 271 (3): 309–323. DOI:10.1016/j.taap.2010.03.019.; Mapp C.E., Boscetto P., Maestrell P., Fabri G.M. Occupational asthma. Am. J. Respir. Crit. Care Med. 2005; 172 (3): 280–305. DOI:10.1164/rccm.200311-1575SO.; Chung C.C., Magalhaes W.C.S., Gonzalez-Bosquet J., Chanock S.J. Genome-wide association studies in cancer–current and future directions. Carcinogenesis. 2010; 31 (1): 111–120. DOI:10.1093/carcin/bgp273.; Cullen A.C., Corrales M.A., Kramer C.B., Faustman E.M. The application of genetic information for regulatory standard setting under the clean air act: a decision-analytic approach. Risk. Anal. 2008; 28 (4): 877–890. DOI:10.1111/j.1539-6924.2008.01084.x.; Dolinoy D.C., Weidman J.R., Jirtle R.L. Epigenetic generegulation: Linking early development to adult disease. Reproduct. Toxicol. 2007; 23: 297–298. DOI:10.1016/j.reprotox.2006.08.012.; Garte S. Individual susceptibility and gene-environment interaction. In: Wild C., Vineis P., Garte S., eds. Molecular Epidemiology of Chronic Disease. West Sussex: John Wiley and Sons, Ltd; 2008: 55–69.; Grodsky J.A. Genetics and environmental law: redefining public health. Calif. Law Rev. 2005; 92 (1): 171–270. DOI:10.15779/Z38QQ74.; Sundberg M. Genetic variability in susceptibility and response to toxicants. Toxicol. Lett. 2005; 120 (1–3): 259–268.; Николаев В.М., Иванова Ф.Г., Чирикова Н.К. и др. Изучение полиморфизма генов GSTT1 и GSTM1 у больных раком легкого в республике Саха. Фундаментальные исследования. 2014; 11: 1949–1953.; Rahman I., MacNee W. Oxidative stress and regulation of glutathione in lung inflammation. Eur. Respir. J. 2000, 16 (3): 534–554.; Murcray C.E., Lewinger J.P., Gauderman W.J. Gene-environment interaction in genome-wide association studies. Am. J. Epidemiol. 2009; 169 (2): 219–226. DOI:10.1093/aje/kwn353.; Department of Health and Human Services Centers for Disease Control and Prevention National Institute for Occupational Safety and Health. Genetics in the Workplace: Implications for Occupational Safety and Health. Genetics Working Group. 2010; 2010-101. Available at: https://www.cdc.gov/niosh/docs/2010-101/pdfs/2010-101.pdf; Кузьмина Л.П., Помыканова Ю.С. Молекулярно-генетические маркеры профессиональной бронхиальной астмы с тяжелым течением. Профилактическая медицина. 2016; 19 (2): 44–45.; Галущинская А.В. Риск развития нейтрофильного воспаления бронхов у детей, болеющих бронхиальной астмой, при делеционном полиморфизме генов GSTT1 и GSTM1. Современные проблемы науки и образования. 2014; 2. https://science-education.ru/ru/article/view?id=12298; Кузьмина Л.П. Роль генетико-биохимических полиморфных систем в формировании профессиональной бронхиальной патологии от воздействия аэрозолей преимущественно фиброгенного действия. В кн.: Измеров Н.Ф., Чучалин А.Г., ред. Профессиональные заболевания органов дыхания. М.: ГЭОТАР-Медиа; 2015: 118–148.; Faisal M., Chellurl P.E., Singaraju S. et al. Environmental and occupational respiratory diseases. Spirometric abnormalities in nonsmoking bus drivers of hyderabad. World Allergy Org. J. 2013; 6 (Suppl. 1): P61. DOI:10.1186/19394551-6-S1-P61.; Васильева О.С., Кулемина Е.А. Бронхиальная астма, вызванная ингаляцией токсико-аллергенных аэрозолей поливинилхлорида. Пульмонология. 2012; (1): 112–116.; Васильева О.С., Кузьмина Л.П., Кулемина Е.А., Коляскина М.М. Клинические и молекулярно-генетические аспекты формирования профессиональной астмы. Пульмонология. 2012; (3): 39–45.; Гланц С. Медико-биологическая статистика. М.: Практика; 1999.; Global Initiative for Asthma – GINA 2016. Available at: http://ginasthma.org/wp-content/uploads/2016/04/wms-GINA-2016-main-report-final.pdf; Global strategy for the diagnosis, management, and prevention of chronicobstructive pulmonary disease, Global Initiative for Chronic Obstructive Lung Disease. 2016. Available at: http://goldcopd.org/guidelines-global-strategy-for-diagnosis-management.html; Buist A.S., McBumie M.A., Vollmer W.M. et al. International variation in the prevalence of COPD (The BOLD Study): a population-based prevalence study. Lancet. 2007; 370 (9589): 741–750. DOI:10.1016/S0140-6736(07)61377-4.; Eisner M.D., Blanc P.D., Omachi T.A. et al. Socioeconomic status, race and COPD health outcomes. J. Epidemiol. Community Health. 2011; 65 (1): 26–34. DOI:10.1136/jech.2009.089722.; Dodd J., Patel B. COPD genetics and epidemiology. In: Maskell N., Millar A., eds. Respiratory medicine. Oxford: Oxford University Press; 2009: 90–104.; https://journal.pulmonology.ru/pulm/article/view/843